First Pathogenic Deep-Intronic SERPINC1 Variant Identified in Hereditary Antithrombin Deficiency – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by P. Christian Remmelzwaal et al, published in JTH, adding:
”Novel SERPINC1 variants in hereditary antithrombin deficiency: first pathogenic deep-intronic variant, revealed by multiple genomic and transcriptomic approaches
Hereditary antithrombin deficiency usually traces to coding mutations in SERPINC1, but some families stay unexplained.
Combining genomic and transcriptomic methods, this study identified several new variants, including the first pathogenic deep-intronic one, which causes deficiency by disrupting splicing. With it, every tested family at the authors’ center now has an identified cause for their antithrombin deficiency.”
Title: Novel SERPINC1 variants in hereditary antithrombin deficiency: first pathogenic deep-intronic variant, revealed by multiple genomic and transcriptomic approaches
Authors: P. Christian Remmelzwaal, René Mulder, Jelkje J. de Boer-Bergsma, Albertus Vinke, Hilde A.M. Kooistra, Nic J.G.M. Veeger, Albertus Wierenga, Jan Jacob Schuringa, Michael Lukens, Karina Meijer

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC